# PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference Canonical URL: https://biopharmsignal.com/news/PRCT/procept-biorobotics-to-attend-the-td-cowen-46th-annual-health-care-conference-an-e92ee5ef Ticker: PRCT Company: PROCEPT BioRobotics Source: PROCEPT BioRobotics Published: 2026-02-04 21:03 EST ## Summary PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing... ## Article Body PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March. TD Cowen 46 th Annual Health Care Conference Location – Boston, MA Fireside Chat – Monday, March 2 nd at 11:40am ET 2026 Leerink Global Health Care Conference Location – Miami, FL Fireside Chat – Tuesday, March 10 th at 8am ET A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com . The webcasts will be archived and available for replay for at least 90 days after the event. About PROCEPT BioRobotics Corporation PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS® Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. Investor Contact: Matt Bacso VP, Investor Relations and Business Operations m.bacso@procept-biorobotics.com ## Recent Company News - 2026-07-14 20:05 EST — [PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026](https://biopharmsignal.com/news/PRCT/procept-biorobotics-to-report-second-quarter-2026-financial-results-on-august-4t-255b7bdd) — Source: PROCEPT BioRobotics - 2026-05-28 12:00 EST — [PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval](https://biopharmsignal.com/news/PRCT/procept-biorobotics-advances-prostate-cancer-program-with-water-iv-study-enrollm-de942ff2) — Source: PROCEPT BioRobotics - 2026-05-14 12:00 EST — [AUA Guidelines Strengthen Recommendation for Aquablation® Therapy](https://biopharmsignal.com/news/PRCT/aua-guidelines-strengthen-recommendation-for-aquablation-therapy-b17aee34) — Source: PROCEPT BioRobotics - 2026-04-30 20:03 EST — [PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June](https://biopharmsignal.com/news/PRCT/procept-biorobotics-to-attend-three-upcoming-investor-conferences-in-may-june-336852ab) — Source: PROCEPT BioRobotics - 2026-04-29 20:03 EST — [PROCEPT BioRobotics Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PRCT/procept-biorobotics-reports-first-quarter-2026-financial-results-c24cd67e) — Source: PROCEPT BioRobotics ## Related News - 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9) - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)